New drug aims to save premature babies' eyesight
Disease control
Recruiting now
This early-stage study tests a new medicine called FLQ-101 in 18 premature babies born at 26-27 weeks who are at high risk for retinopathy of prematurity (ROP), an eye disease that can cause blindness. The main goal is to check if the drug is safe and how it works in the body. Re…
Phase: PHASE1 • Sponsor: FELIQS INC. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC